Edward McCoul, MD
Otolaryngology · New Orleans, LANPI 1629268818
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $60,834 of the $91,910 with a category attached, or 66.2%. 16 manufacturers reported payments, led by Stryker at 57.4% of the total. Among otolaryngology clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 150 payments — averaging $612.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$53K
- Sanofi$20K
- Optinose US, Inc.$8K
- Regeneron Healthcare Solutions, Inc.$6K
- Medtronic$2K
- Aerin Medical Inc.$2K
- plus $2K from 10 others
Across 12 payments — averaging $4930.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Optinose US, Inc.$27K
- Roche Products Limited$17K
- Stryker$15K
What the payments were for
- Consulting fees$60,83466%
- Speaking & faculty fees$20,57822%
- Travel & lodging$2,1512%
- Food & beverage$8,3479%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 67 | $52,719 |
| Sanofi | 15 | $19,629 |
| Optinose US, Inc. | 9 | $7,787 |
| Regeneron Healthcare Solutions, Inc. | 8 | $6,014 |
| Medtronic | 15 | $1,751 |
| Aerin Medical Inc. | 13 | $1,539 |
| 3-d Matrix, Inc. | 2 | $664 |
| Neurent Medical Limited | 3 | $425 |
| Inspire Medical Systems, Inc. | 3 | $276 |
| Acclarent, Inc | 2 | $248 |
| Integra Lifesciences Corporation | 2 | $205 |
| Intersect ENT, Inc. | 2 | $190 |
| Arrinex, Inc. | 1 | $160 |
| GSK | 5 | $129 |
| Cook Medical LLC | 2 | $95 |
| Cochlear Americas | 1 | $77 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XPRESS ENT DILATION SYSTEM$38,392
- DUPIXENT$34,065
- CLARIFIX CRYOTHERAPY DEVICE$19,145
- LATERA$17,568
- SCOPIS ENT$17,500
- TGS GUIDEWIRE$15,900
- SHAVER SYSTEM$12,922
- Xhance$7,499
- ENTELLUS - XPRESS ENT DILATION SYSTEM$3,532
- PROPEL$714
- VIVAER STYLUS$644
- RHINAER STYLUS$644
- XPRESS LOPROFILE$600
- ENTELLUS MEDICAL FOCESS SINUSCOPE$400
- ORTHOMAP$400
- NEUROMARK System$366
- NEUROMARK Radiofrequency Console$366
- PTEYE PARATHYROID DETECTION SYSTEM$306
- Acclarent Aera$254
- Inspire$253
How this compares
$91,910 in reported general payments places this provider in the 95th percentile of 218 otolaryngology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XhanceFluticasone Propionate | 15 | $8,881 |
| Azelastine Hcl | 39 | $1,031 |
| Fluticasone Propionate | 51 | $973 |
| Ipratropium Bromide | 23 | $737 |
| Famotidine | 25 | $365 |
| Mupirocin | 17 | $354 |
| Doxycycline Monohydrate | 23 | $247 |
| Ciprofloxacin Hcl | 17 | $225 |
| Omeprazole | 12 | $175 |
| Pantoprazole Sodium | 11 | $114 |
| Amoxicillin | 18 | $53 |
| Levocetirizine Dihydrochloride | 12 | $48 |
| Prednisone | 15 | $28 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Optinose US, Inc.Xhance | $7,787 | $8,88115 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 218 otolaryngology providers in Louisiana.
Other otolaryngology in New Orleans
- Donald GonzalesNew Orleans$351K
- Rohan WalvekarNew Orleans$21K
- Jonathan OwensNew Orleans$7K
- Paul FriedlanderNew Orleans$6K
- Grayson GremillionNew Orleans$4K
- Newland WorleyNew Orleans$4K
- Jacqueline MagneNew Orleans$3K
- Kevin McLaughlinCovington$186K
- Adil FatakiaMarrero$148K
- Michael YimShreveport$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.